COL13A Inhibitors
Inhibitors classified as COL13A inhibitors would refer to a group of compounds that specifically target the activity of the protein encoded by the COL13A1 gene. This gene is responsible for producing the type XIII collagen alpha-1 chain, a transmembrane collagen that is implicated in the organization of the extracellular matrix (ECM). Type XIII collagen is known to contribute to the structural integrity of various tissues by facilitating cell-to-matrix interactions. It is distinguished from other collagen types by its shorter triple-helical domain and its transmembrane nature, which allows it to perform unique roles in cell adhesion and signaling. COL13A inhibitors would be designed to interfere with the expression, processing, or function of the type XIII collagen alpha-1 chain, aiming to elucidate the physiological roles of this collagen type by observing the effects of its inhibition. The identification of such molecules typically involves the utilization of chemical library screens, where a multitude of compounds are evaluated for their ability to specifically modulate the activity or stability of type XIII collagen.
To confirm and characterize the action of COL13A inhibitors, a series of in-depth biochemical and structural analyses would be conducted. These analyses may include assessing the binding affinity of the inhibitors to the collagen XIII alpha-1 chain, and examining their impact on the post-translational modifications that are essential for the proper function of the collagen. Advanced imaging techniques such as cryo-electron microscopy might be employed to observe the effects of inhibitors on the collagen's conformation and its integration into the ECM. Furthermore, the selectivity of these inhibitors is crucial, necessitating rigorous specificity tests to ensure that they do not unintentionally affect other collagen types or ECM components. Such specificity is vital for the accurate interpretation of results and for understanding the unique contributions of type XIII collagen to tissue architecture and function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound demethylates DNA, which could potentially upregulate or downregulate gene expression, depending on the gene context. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As an HDAC inhibitor, it may change chromatin structure, potentially downregulating specific gene expression, potentially including "COL13A". | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Another HDAC inhibitor, possibly affecting gene expression by altering chromatin acetylation patterns. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
A DNA methyltransferase inhibitor that could lead to hypomethylation and altered gene expression patterns. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Similar to 5-Azacytidine, it may cause DNA demethylation and affect gene expression. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
By inhibiting HDAC, it could affect "COL13A" expression through changes in chromatin state. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR signaling that might indirectly affect protein synthesis and gene expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Known to modulate various transcription factors and signaling pathways that could influence gene expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Has been shown to interact with multiple molecular targets which could affect gene expression patterns. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
May activate transcription factors that could lead to changes in gene expression, including "COL13A". | ||||||